ArticlePeerJ2025

Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma.

Lin Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.